About James Boylan
James Boylan is a director at Zenas BioPharma.
James Boylan reports to the SEC as a director of 4 public companies, including Immunome (IMNM), Compass Therapeutics (CMPX) and Camp4 Therapeutics (CAMP).
James Boylan first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name James Boylan in the role, so the role may have started earlier or lasted longer.
II
Immunome Inc.
Director
2023 – 2026 · Public company (IMNM)
CI
Compass Therapeutics, Inc.
Director
2022 – 2026 · Public company (CMPX)
CC
Camp4 Therapeutics Corp
Director
2024 – 2025 · Public company (CAMP)
Key Colleagues at Startups
The people James Boylan works with at each company, as listed on that company's latest Form D.
Zenas BioPharma, Inc. · Form D, May 14, 2024
PE
Patrick Enright
Director
TK
Tomas Kiselak
Director
PA
Patricia Allen
Director
JF
Joseph Farmer
PRESIDENT and CHIEF OPERATING OFFICER
LJ
Leon Moulder, Jr.
Executive officer and director
JN
Jake Nunn
Director
TX
Tim Xiao
Director
JF
Jennifer Fox
Executive officer
TF
Tanya Fischer
Executive officer
JO
John Orloff
Director
HL
Hongbo Lu
Director